Question 1

Does Balyasny Asset Management own AQST stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Balyasny Asset Management holds 744,536 shares of AQST (Aquestive Therapeutics), worth $3.1M.

Question 2

How many shares of AQST does Balyasny Asset Management own?

Accepted Answer

As of its Q2 2026 13F, Balyasny Asset Management holds 744,536 shares of AQST (Aquestive Therapeutics).

Question 3

What is Balyasny Asset Management's AQST position worth?

Accepted Answer

As of its Q2 2026 13F, Balyasny Asset Management's AQST position is worth $3.1M.

Question 4

Is Balyasny Asset Management buying or selling AQST?

Accepted Answer

In Q2 2026, Balyasny Asset Management reduced its AQST position by 2,156,034 shares (-74.3%).

Question 5

When did Balyasny Asset Management first buy AQST?

Accepted Answer

Balyasny Asset Management first reported AQST in its Q3 2021 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	744,536	-74.3%	$3.1M	0.0%	$4.16	0
2026-Q1	Increased	2.9M	+198.7%	$12M	0.0%	$4.15	45
2025-Q4	New	970,939	-	$6.3M	0.0%	$6.46	38
2024-Q4	Exited	0	-100.0%	$0	0.0%	$3.56	0
2024-Q3	New	28,937	-	$144,106	0.0%	$4.98	31

AQSTShowing 5 of 7 quarters

AQST
Showing 5 of 7 quarters